LPL Financial’s Alterity Therapeutics ATHE Stock Holding History

LPL Financial’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-170	Closed	-$7K	–	3111
2015 Q4	$7K	Buy	+170	New	+$8.65K	﹤0.01%	3138

Other funds holding ATHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

MFS

MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

LPL Financial's ATHE Position: Q1 2016 in Review

LPL Financial sold out of Alterity Therapeutics (ATHE) in Q1 2016, closing a stake of 170 shares — an estimated $7K sold.

LPL Financial first reported a position in ATHE in Q4 2015 and held it in 1 quarter. The position peaked at $7K in Q4 2015. 14 funds tracked by Wall St. Rank hold ATHE as of Q1 2016.

LPL Financial reported no remaining Alterity Therapeutics position as of Q1 2016 after selling out during the quarter.
LPL Financial sold 170 Alterity Therapeutics shares in Q1 2016, an estimated $7K.
LPL Financial first reported a position in Alterity Therapeutics in Q4 2015 and held it in 1 quarter.
LPL Financial's Alterity Therapeutics position peaked at $7K in Q4 2015.
14 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2016.

Based on LPL Financial's 13F filing for Q1 2016, filed 16 May 2016.